Kymera Therapeutics, Inc. Quarterly Return On Assets in % from Q2 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Kymera Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2021 to Q3 2024.
  • Kymera Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -20.3 %, a 28.9% increase year-over-year.
  • Kymera Therapeutics, Inc. annual Return On Assets for 2023 was -25.3 %, a 4.89% increase from 2022.
  • Kymera Therapeutics, Inc. annual Return On Assets for 2022 was -26.6 %, a 42.5% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -20.3 +8.22 +28.9% Jul 1, 2024 Sep 30, 2024
Q2 2024 -22.4 +3.49 +13.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -24 +2.76 +10.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -25.3 +1.3 +4.89% Oct 1, 2023 Dec 31, 2023
Q3 2023 -28.5 -2.09 -7.92% Jul 1, 2023 Sep 30, 2023
Q2 2023 -25.9 -1.98 -8.29% Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.7 -4.69 -21.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -26.6 -7.93 -42.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -26.4 -10.8 -69.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 -23.9 -11.6 -93.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -22.1 Jan 1, 2022 Mar 31, 2022
Q4 2021 -18.7 Oct 1, 2021 Dec 31, 2021
Q3 2021 -15.6 Jul 1, 2021 Sep 30, 2021
Q2 2021 -12.3 Apr 1, 2021 Jun 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.